- Prediction of Sildenafil Response according to Intracavernosal Injection Test in Patients with Erectile Dysfunction
-
Lee JS, Jung SI, Park K
- KMID: 2226616
- Korean J Androl.
- 2006 Dec;24(3):139-143.
PURPOSE: The aim of our study was to assess whether an intracavernous injection test can predict the effectiveness of sildenafil oral medication in patients with erectile dysfunction (ED). MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Trimix Intracavernosal Injection Therapy in Patients with Erectile Dysfunction: Long-term Follow-up Result
-
Chung TG, Park M, Kim T, Lee J, Ahn TY
- KMID: 2290462
- Korean J Urol.
- 1998 Nov;39(11):1129-1135.
PURPOSE: Vasoactive pharmacotherapy is now being widely used as practical and reliable method for the treatment of the patients with erectile dysfunction. The synergistic effect and low drug volume of... -
- CITED
-
- Close
- SHARE
-
- Close
- Trimix Intracavernosal Self-injection Therapy: Long-term Follow-up Results in the Patients with Erectile Dysfunction
-
Paick JS, Lee KC, Kim SW, Lee C, Kim SW
- KMID: 2289992
- Korean J Urol.
- 1998 Sep;39(9):911-915.
PURPOSE: Trimix, the mixture of papaverine, phentolamine and PGE1 , has been widely used in intracavernosal therapy for patients with erectile dysfunction. Although several results have been reported in Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Intracavernosal Self-Injection Therapy for the Patients with Erectile Dysfunction: Comparison of Erectile Response and Complications between Bimix and Trimix Solution
-
Seo KK, Song KK, Kim SC
- KMID: 2060712
- Korean J Urol.
- 1997 Mar;38(3):306-311.
PURPOSE: To compare the efficacy of Bimix solution (27.3 mg/ml papaverine and 0.9 mg/ml phentolamine) versus Trimix solution (18.8 mg/ml papaverine, 0.6 mg/ml phentolamine and 6.3ug/ml prostaglandin El) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Trimix Intracavernosal Injection Therapy in the Patients with Erectile Dysfunction
-
Ahn TY, Chung TK, Park HK, Kim KS, Choo MS
- KMID: 2060595
- Korean J Urol.
- 1995 Jun;36(6):651-657.
Vasoactive pharmacotherapy is now being widely used as practical and reliable method for the treatment of the patients with erectile dysfunction. But the individual vasoactive agent has limitations in its... -
- CITED
-
- Close
- SHARE
-
- Close
